株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

マイクロビオーム治療薬の世界市場の分析:産業分析、市場規模・シェア・成長率・動向・予測

Global Microbiome Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast till 2025

発行 Value Market Research 商品コード 739335
出版日 ページ情報 英文 107 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
マイクロビオーム治療薬の世界市場の分析:産業分析、市場規模・シェア・成長率・動向・予測 Global Microbiome Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast till 2025
出版日: 2019年06月01日 ページ情報: 英文 107 Pages
概要

当レポートでは、世界のマイクロビオーム (微生物叢) 治療薬の市場について分析し、製品の特性や市場の基本構造、主な市場促進・抑制要因、全体的な市場動向の推移と見通し、種類別・用途別・地域別の詳細動向、市場競争環境、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 エグゼクティブ・サマリー

第3章 市場分析

  • イントロダクション
  • バリューチェーン分析
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • ポーターのファイブフォース分析

第4章 マイクロビオーム治療薬市場の分析:種類別

  • 糞便微生物叢移植 (FMT)
  • 薬剤

第5章 マイクロビオーム治療薬市場の分析:用途別

  • クロストリジウム・ディフィシル (C. difficile) 感染症
  • クローン病
  • 炎症性腸疾患
  • 糖尿病
  • その他

第6章 マイクロビオーム治療薬市場の分析:地域別

  • 北米 (米国、カナダ)
    • 市場規模 (推定値)
    • 市場規模:国別 (推定値)
  • 欧州 (英国、ドイツ、フランスなど)
  • アジア太平洋地域 (中国、日本、インドなど)
  • ラテンアメリカ (ブラジルなど)
  • 中東・アフリカ

第7章 マイクロビオーム治療薬企業:競争環境

  • 市場競争
  • 事業提携・協力、合意
  • 企業合併・買収 (M&A)
  • 新製品の発売
  • その他の動き

第8章 マイクロビオーム治療薬業界の企業プロファイル (企業概要、財務分析、主要製品、近年の動向)

  • Enterome Bioscience
  • MaaT Pharma
  • MicroBiome Therapeutics LLC
  • OpenBiome
  • Rebiotix, Inc.
  • Ritter Pharmaceuticals Inc.
  • Second Genome
  • Seres Therapeutics Inc.
目次

The report on global microbiome therapeutics market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2025. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

  • Drivers
  • Increasing consumer awareness
  • Robust product pipeline
  • Restraints
  • Cost factor

    Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

    • Base Year: 2018
    • Estimated Year: 2019
    • Forecast Till: 2025
    • The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
    • The report classifies the market into different segments based on type and application. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
    • The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc., Ritter Pharmaceuticals Inc., Second Genome and Seres Therapeutics Inc. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

    SEGMENTATIONS IN THE REPORT:

    By Type:

    • FMT
    • Microbiome Drugs

    By Applications:

    • C. Difficile
    • Crohn's Disease
    • Inflammatory Bowel Disease
    • Diabetes
    • Others

    By Geography:

    • North America (NA) - US, Canada & Rest of North America
    • Europe (EU) - UK, Germany, France & Rest of Europe
    • Asia Pacific (APAC) - China, Japan, India & Rest of APAC
    • Latin America (LA) - Brazil & Rest of Latin America
    • Middle East & Africa (MEA) - Middle East and Africa

    Table of Contents

    1. INTRODUCTION

    Report Description

  • Research Scope
  • Research Methodology

    2. EXECUTIVE SUMMARY

    • Market Highlight
    • Global Microbiome Therapeutics Market: Snapshot

    3. MARKET ANALYSIS

    • Introduction
    • Value Chain Analysis
    • Drivers
    • Restraints
    • Opportunities
    • Porter's Five Forces Analysis

    4. MICROBIOME THERAPEUTICS MARKET ANALYSIS BY TYPE

    • Market In FMT
    • Market In Microbiome Drugs

    5. MICROBIOME THERAPEUTICS MARKET ANALYSIS BY APPLICATION

    • Market In C. Difficile
    • Market In Crohn's Disease
    • Market In Inflammatory Bowel Disease
    • Market In Diabetes
    • Market In Others

    6. MICROBIOME THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

    • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.)
    • Canada
    • Rest Of North America
    • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK)
    • Germany
    • France
    • Rest Of Europe
    • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country
    • China
    • Japan
    • India
    • Rest Of Asia Pacific
    • Latin America (LA)
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil
    • Rest Of Latin America
    • Middle East And Africa (MEA)
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East
    • Africa

    7. COMPETITIVE LANDSCAPE OF THE MICROBIOME THERAPEUTICS COMPANIES

    • Market Competition
    • Partnerships/Collaborations/Agreements
    • Mergers And Acquisitions
    • New Product Launches
    • Other Developments

    8. COMPANY PROFILES OF THE MICROBIOME THERAPEUTICS INDUSTRY (Company Overview, Financial, Major Products & Recent Development)

    • Enterome Bioscience
    • MaaT Pharma
    • MicroBiome Therapeutics LLC
    • OpenBiome
    • Rebiotix, Inc.
    • Ritter Pharmaceuticals Inc.
    • Second Genome
    • Seres Therapeutics Inc.
    • Tentative TOC
  • Back to Top